Woodcock Tries To Calm US FDA Staff Fears About Trump
Executive Summary
CDER Director's' video advises focusing on the work and "keeping our heads down."
You may also be interested in...
Even As Acting US FDA Commissioner, Woodcock Still Holds Multiple Positions
To help with the transition to Biden’s COVID-19 response, Woodcock will retain some therapeutic development duties in the program the Trump administration had called Operation Warp Speed.
President ????: What US Election Uncertainty Means For Biopharma
Worst case scenario is civil unrest that might disrupt clinical trials and manufacturing. Under a more moderate scenario, companies must delay business planning because the US policy environment remains cloudy.
President ????: What US Election Uncertainty Means For Biopharma
Worst case scenario is civil unrest that might disrupt clinical trials and manufacturing. Under a more moderate scenario, companies must delay business planning because the US policy environment remains cloudy.